Nexgel, Inc. (NXGL): Depreciation & Amortization
$450.0K
Year ended 2025-12-31
$1.15M
Trailing 12 months to 2026-06-30
+59.0%
3-year compound annual growth
+55.2%
5-year compound annual growth
| Period ended | Depreciation & Amortization | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $450.0K | +3.2% | 2026-03-31, From 2025-01-01 |
| 2024-12-31 | $436.0K | +92.9% | 2026-03-31, From 2024-01-01 |
| 2023-12-31 | $226.0K | +101.8% | 2025-03-27, From 2023-01-01 |
| 2022-12-31 | $112.0K | -0.9% | 2024-04-10, From 2022-01-01 |
| 2021-12-31 | $113.0K | +126.0% | 2023-03-28, From 2021-01-01 |
| 2020-12-31 | $50.0K | -25.4% | 2022-03-21, From 2020-01-01 |
| 2019-12-31 | $67.0K | -79.2% | 2021-03-31, From 2019-01-01 |
| 2018-12-31 | $322.0K | n/a | 2020-04-03, From 2018-01-01 |
Depreciation & Amortization at similar companies
| Company | Year ended | Depreciation & Amortization | Change YoY |
|---|---|---|---|
| Nexgel, Inc. (NXGL) | 2025-12-31 | $450.0K | +3.2% |
| WORK Medical Technology Group LTD (WOK) | 2025-09-30 | $923.1K | -34.6% |
| Medinotec Inc. (MDNC) | 2026-02-28 | $80.9K | +9.5% |
| Neuroone Medical Technologies Corp (NMTC) | 2025-09-30 | $261.7K | +6.0% |
| InspireMD, Inc. (NSPR) | 2025-12-31 | $476.00M | +70.0% |
| Allurion Technologies, Inc. (ALUR) | 2025-12-31 | $983.0K | -1.4% |
| Beyond Air, Inc. (XAIR) | 2026-03-31 | $3.10M | +3.3% |
| Vivos Therapeutics, Inc. (VVOS) | 2025-12-31 | $1.31M | +125.3% |
| Nephros Inc (NEPH) | 2025-12-31 | $140.0K | +3.7% |
Compare NXGL, WOK, MDNC, NMTC side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗